 Connection
Paul Awolade to Antineoplastic Agents
This is a "connection" page, showing publications Paul Awolade has written about Antineoplastic Agents.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.846 |
|
|
|
-
Awolade P, Cele N, Ebenezer O, Kerru N, Gummidi L, Gu L, Palma G, Kaur M, Singh P. Synthesis of 1H-1,2,3-Triazole-Linked Quinoline-Isatin Molecular Hybrids as Anti-Breast Cancer and Anti-Methicillin-Resistant Staphylococcus aureus (MRSA) Agents. Anticancer Agents Med Chem. 2021; 21(10):1228-1239.
Score: 0.330
-
Prigaro BJ, Esquer H, Zhou Q, Pike LA, Awolade P, Lai XH, Abraham AD, Abbott JM, Matter B, Kompella UB, Messersmith WA, Gustafson DL, LaBarbera DV. Design, Synthesis, and Biological Evaluation of the First Inhibitors of Oncogenic CHD1L. J Med Chem. 2022 03 10; 65(5):3943-3961.
Score: 0.089
-
Kumar V, Dhawan S, Girase PS, Awolade P, Shinde SR, Karpoormath R, Singh P. Recent Advances in Chalcone-Based Anticancer Heterocycles: A Structural and Molecular Target Perspective. Curr Med Chem. 2021 Oct 25; 28(33):6805-6845.
Score: 0.087
-
Seboletswe P, Awolade P, Singh P. Recent Developments on the Synthesis and Biological Activities of Fused Pyrimidinone Derivatives. ChemMedChem. 2021 07 06; 16(13):2050-2067.
Score: 0.084
-
Gummidi L, Kerru N, Awolade P, Raza A, Sharma AK, Singh P. Synthesis of indole-tethered [1,3,4]thiadiazolo and [1,3,4]oxadiazolo[3,2-a]pyrimidin-5-one hybrids as anti-pancreatic cancer agents. Bioorg Med Chem Lett. 2020 11 15; 30(22):127544.
Score: 0.081
-
Dhawan S, Awolade P, Kisten P, Cele N, Pillay AS, Saha S, Kaur M, Jonnalagadda SB, Singh P. Synthesis, Cytotoxicity and Antimicrobial Evaluation of New Coumarin-Tagged ?-Lactam Triazole Hybrid. Chem Biodivers. 2020 Jan; 17(1):e1900462.
Score: 0.077
-
Dhawan S, Kerru N, Awolade P, Singh-Pillay A, Saha ST, Kaur M, Jonnalagadda SB, Singh P. Synthesis, computational studies and antiproliferative activities of coumarin-tagged 1,3,4-oxadiazole conjugates against MDA-MB-231 and MCF-7 human breast cancer cells. Bioorg Med Chem. 2018 11 15; 26(21):5612-5623.
Score: 0.071
-
Sala R, Esquer H, Kellett T, Clune S, Awolade P, Pike LA, Zhou Q, Messersmith WA, LaBarbera DV. CHD1L Inhibitor OTI-611 Synergizes with Chemotherapy to Enhance Antitumor Efficacy and Prolong Survival in Colorectal Cancer Mouse Models. Int J Mol Sci. 2024 Dec 07; 25(23).
Score: 0.027
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|